Joint Clinical Trials Office

You are here

News

Dr. Ronald Crystal
Dr. Ronald Crystal

New Gene Therapy Protects Against Peanut Allergy

A new gene therapy developed by scientists at Weill Cornell Medicine could eventually prevent the life-threatening effects of peanut allergy with just a single dose, according to a new pre-clinical study.

Peanuts are the most common food that induces fatal or near-fatal reactions in those who are allergic to them, yet preventive treatment is limited. In their study,...

Read More
Dr. John P. Leonard
Dr. John P. Leonard

The Leukemia & Lymphoma Society Names John P. Leonard, MD of Weill Cornell Medicine and NewYork-Presbyterian its 2016 Manhattan Light The Night Corporate Chair

 The New York City Chapter of The Leukemia & Lymphoma Society (LLS) has announced John P. Leonard, MD, of Weill Cornell Medicine and NewYork-Presbyterian as its 2016 Manhattan Light The Night® corporate chair. Light The Night is LLS's largest annual fundraising event held each fall to find cures...

Read More
Dr. Art Sedrakyan Photo credit: Carlos Rene Perez
Dr. Art Sedrakyan Photo credit: Carlos Rene Perez

Scientists Propose a Framework for More Comprehensive Assessment of Medical Device Safety and Efficacy

Every medicine we take has been extensively trialled to prove it is safe and it works, but the same standards do not necessarily apply to medical devices like joint replacements, surgical mesh or pacemakers. Now, a group of researchers led by Oxford University and Weill Cornell Medicine has...

Read More
Dr. David Cohen
Dr. David Cohen

Dr. David E. Cohen Named Chief of Division of Gastroenterology and Hepatology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center

 Dr. David E. Cohen, an internationally renowned physician-scientist who combines clinical care as a hepatologist with research focused on obesity-related liver disease, has been named chief of the Division of Gastroenterology and Hepatology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1.

Dr. Cohen will...

Read More
Dr. Adrienne Phillips
Dr. Adrienne Phillips

Innovative Immunotherapy More Effective in Treating an Aggressive Lymphoma than Chemotherapy

A drug that recruits immune cells to fight an aggressive form of lymphoma that disproportionately affects minorities in the United States appears to be more effective than chemotherapy, according to new research from Weill Cornell Medicine and NewYork-Presbyterian.

The findings of a small clinical trial demonstrate that the antibody drug mogamulizumab, known as moga, induces...

Read More

Researcher's Toolbox

Contact Information

Joint Clinical Trials Office Weill Cornell Medicine /
NewYork-Presbyterian
1300 York Avenue,
Box 305
New York, NY 10065 Phone: (646) 962-8215 Fax: (646) 962-0536

Abbreviation Library